Narayanan Padma Kumar, Li Nianyu
Amgen Seattle, Seattle, Washington.
Curr Protoc Toxicol. 2019 Feb;79(1):e68. doi: 10.1002/cptx.68. Epub 2019 Jan 23.
Phagocytosis of platelets by monocytes and macrophages is a primary mechanism of platelet clearance in vivo and has been increasingly implicated in playing an important role in thrombocytopenia mediated by monoclonal antibodies intended for therapeutic purposes. In the present article, we describe an in vitro flow cytometry assay to assess the effect of antibody-mediated platelet phagocytosis by monocytes. Freshly isolated platelets were labeled with a fluorescent probe, 5-chloromethylfluorescein diacetate (CMFDA) and then co-cultured with isolated peripheral blood mononuclear cells (PBMCs) from the same donor in the presence of increasing concentrations of a monoclonal antibody drug. After incubation, an increase in CMFDA fluorescence intensity of CD14 positive monocytes was evaluated by flow cytometry as an assessment for drug-mediated platelet phagocytosis by monocytes. The assay has been evaluated using both human and cynomolgus monkey cells for the prediction of drug-induced thrombocytopenia. © 2019 by John Wiley & Sons, Inc.
单核细胞和巨噬细胞对血小板的吞噬作用是体内血小板清除的主要机制,并且越来越多地被认为在治疗性单克隆抗体介导的血小板减少症中起重要作用。在本文中,我们描述了一种体外流式细胞术检测方法,用于评估抗体介导的单核细胞对血小板的吞噬作用。将新鲜分离的血小板用荧光探针5-氯甲基荧光素二乙酸酯(CMFDA)标记,然后在浓度递增的单克隆抗体药物存在下,与来自同一供体的分离外周血单个核细胞(PBMC)共培养。孵育后,通过流式细胞术评估CD14阳性单核细胞的CMFDA荧光强度增加,作为单核细胞对药物介导的血小板吞噬作用的评估。该检测方法已使用人细胞和食蟹猴细胞进行评估,以预测药物诱导的血小板减少症。©2019约翰威立国际出版公司